Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.

Khozin S, Miksad RA, Adami J, Boyd M, Brown NR, Gossai A, Kaganman I, Kuk D, Rockland JM, Pazdur R, Torres AZ, Zhi J, Abernethy AP.

Cancer. 2019 Nov 15;125(22):4019-4032. doi: 10.1002/cncr.32383. Epub 2019 Aug 5.

PMID:
31381142
2.

Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.

Singal G, Miller PG, Agarwala V, Li G, Kaushik G, Backenroth D, Gossai A, Frampton GM, Torres AZ, Lehnert EM, Bourque D, O'Connell C, Bowser B, Caron T, Baydur E, Seidl-Rathkopf K, Ivanov I, Alpha-Cobb G, Guria A, He J, Frank S, Nunnally AC, Bailey M, Jaskiw A, Feuchtbaum D, Nussbaum N, Abernethy AP, Miller VA.

JAMA. 2019 Apr 9;321(14):1391-1399. doi: 10.1001/jama.2019.3241.

3.

An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records database.

Carrigan G, Whipple S, Taylor MD, Torres AZ, Gossai A, Arnieri B, Tucker M, Hofmeister PP, Lambert P, Griffith SD, Capra WB.

Pharmacoepidemiol Drug Saf. 2019 May;28(5):572-581. doi: 10.1002/pds.4758. Epub 2019 Mar 14. Erratum in: Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1278-1279.

4.

Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.

Khozin S, Carson KR, Zhi J, Tucker M, Lee SE, Light DE, Curtis MD, Bralic M, Kaganman I, Gossai A, Hofmeister P, Torres AZ, Miksad RA, Blumenthal GM, Pazdur R, Abernethy AP.

Oncologist. 2019 May;24(5):648-656. doi: 10.1634/theoncologist.2018-0307. Epub 2018 Dec 27.

PMID:
30591549
5.

Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study.

Agarwala V, Khozin S, Singal G, O'Connell C, Kuk D, Li G, Gossai A, Miller V, Abernethy AP.

Health Aff (Millwood). 2018 May;37(5):765-772. doi: 10.1377/hlthaff.2017.1579. Review.

PMID:
29733723
6.

Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval.

Khozin S, Abernethy AP, Nussbaum NC, Zhi J, Curtis MD, Tucker M, Lee SE, Light DE, Gossai A, Sorg RA, Torres AZ, Patel P, Blumenthal GM, Pazdur R.

Oncologist. 2018 Mar;23(3):328-336. doi: 10.1634/theoncologist.2017-0353. Epub 2018 Jan 9.

7.

Rice Consumption and Squamous Cell Carcinoma of the Skin in a United States Population.

Gossai A, Zens MS, Punshon T, Jackson BP, Perry AE, Karagas MR.

Environ Health Perspect. 2017 Sep 7;125(9):097005. doi: 10.1289/EHP1065.

8.

Maternal and infant inflammatory markers in relation to prenatal arsenic exposure in a U.S. pregnancy cohort.

Farzan SF, Brickley EB, Li Z, Gilbert-Diamond D, Gossai A, Chen Y, Howe CG, Palys T, Karagas MR.

Environ Res. 2017 Jul;156:426-433. doi: 10.1016/j.envres.2017.03.056. Epub 2017 Apr 12.

9.

Assessment of human dietary exposure to arsenic through rice.

Davis MA, Signes-Pastor AJ, Argos M, Slaughter F, Pendergrast C, Punshon T, Gossai A, Ahsan H, Karagas MR.

Sci Total Environ. 2017 May 15;586:1237-1244. doi: 10.1016/j.scitotenv.2017.02.119. Epub 2017 Feb 21. Review.

10.

Maternal arsenic exposure and gestational diabetes and glucose intolerance in the New Hampshire birth cohort study.

Farzan SF, Gossai A, Chen Y, Chasan-Taber L, Baker E, Karagas M.

Environ Health. 2016 Nov 8;15(1):106.

11.

Sex hormones and the risk of keratinocyte cancers among women in the United States: A population-based case-control study.

Kuklinski LF, Zens MS, Perry AE, Gossai A, Nelson HH, Karagas MR.

Int J Cancer. 2016 Jul 15;139(2):300-9. doi: 10.1002/ijc.30072. Epub 2016 Apr 15.

12.

Prospective Study of Human Polyomaviruses and Risk of Cutaneous Squamous Cell Carcinoma in the United States.

Gossai A, Waterboer T, Nelson HH, Doherty JA, Michel A, Willhauck-Fleckenstein M, Farzan SF, Christensen BC, Hoen AG, Perry AE, Pawlita M, Karagas MR.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):736-44. doi: 10.1158/1055-9965.EPI-15-1111. Epub 2016 Feb 11.

13.

Human polyomaviruses and incidence of cutaneous squamous cell carcinoma in the New Hampshire skin cancer study.

Gossai A, Waterboer T, Hoen AG, Farzan SF, Nelson HH, Michel A, Willhauck-Fleckenstein M, Christensen BC, Perry AE, Pawlita M, Karagas MR.

Cancer Med. 2016 Jun;5(6):1239-50. doi: 10.1002/cam4.674. Epub 2016 Feb 21.

14.

Seroepidemiology of Human Polyomaviruses in a US Population.

Gossai A, Waterboer T, Nelson HH, Michel A, Willhauck-Fleckenstein M, Farzan SF, Hoen AG, Christensen BC, Kelsey KT, Marsit CJ, Pawlita M, Karagas MR.

Am J Epidemiol. 2016 Jan 1;183(1):61-9. doi: 10.1093/aje/kwv155. Epub 2015 Dec 13.

15.

Drinking Water Arsenic Contamination, Skin Lesions, and Malignancies: A Systematic Review of the Global Evidence.

Karagas MR, Gossai A, Pierce B, Ahsan H.

Curr Environ Health Rep. 2015 Mar;2(1):52-68. doi: 10.1007/s40572-014-0040-x. Review.

16.

Association between maternal urinary arsenic species and infant cord blood leptin levels in a New Hampshire Pregnancy Cohort.

Gossai A, Lesseur C, Farzan S, Marsit C, Karagas MR, Gilbert-Diamond D.

Environ Res. 2015 Jan;136:180-6. doi: 10.1016/j.envres.2014.10.005. Epub 2014 Nov 20.

Supplemental Content

Loading ...
Support Center